Andrew D Dick Selected Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis)

1/2021	Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.
1/2010	Plasmapheresis in the management of choroidal vasculitis associated with C-anca positive renal vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew D Dick Research Topics

Disease

63	Uveitis 10/2021 - 11/2004
59	Inflammation (Inflammations) 08/2023 - 07/2002
13	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 01/2010
10	Necrosis 01/2021 - 11/2004
9	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 11/2007
9	Posterior Uveitis 01/2021 - 06/2004
8	Panuveitis 10/2022 - 06/2011
8	Choroidal Neovascularization 11/2020 - 09/2013
7	Autoimmune Diseases (Autoimmune Disease) 12/2022 - 11/2005
6	Intermediate Uveitis (Chronic Cyclitis) 01/2021 - 05/2005
6	Ganglion Cysts (Ganglion) 11/2020 - 11/2002
6	Infections 01/2016 - 07/2010
5	Glaucoma 09/2022 - 03/2016
4	Retinal Degeneration 09/2022 - 05/2003
4	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2022 - 04/2010
4	Body Weight (Weight, Body) 01/2019 - 01/2014
4	Hypoxia (Hypoxemia) 01/2019 - 09/2010
3	Arthritis (Polyarthritis) 01/2023 - 01/2014
3	Blindness (Hysterical Blindness) 01/2022 - 03/2016
3	Macular Edema 01/2021 - 06/2004
3	Multiple Sclerosis 10/2017 - 02/2012
3	Eye Diseases (Eye Disease) 09/2017 - 04/2013
3	Cataract (Cataracts) 03/2016 - 08/2003
3	Disease Progression 07/2014 - 12/2008
3	Behcet Syndrome (Behcet's Syndrome) 04/2013 - 11/2007
2	White Dot Syndromes 05/2023 - 06/2011
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021 - 01/2010
2	Scleritis (Episcleritis) 01/2021 - 01/2021
2	Retinal Diseases 09/2019 - 05/2013
2	Graves Ophthalmopathy 01/2018 - 01/2008
2	Multifocal Choroiditis 01/2018 - 06/2011
2	Anterior Uveitis 04/2016 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015 - 06/2004
2	Neuroblastoma 01/2010 - 06/2008
1	Ebola Hemorrhagic Fever 05/2023
1	Neurosyphilis (General Paresis of the Insane) 10/2022
1	Refractive Errors (Refractive Error) 11/2020

Drug/Important Bio-Agent (IBA)

25	Retinaldehyde (Retinal)IBA 05/2023 - 08/2003
16	Adalimumab (Humira)FDA Link 01/2021 - 11/2007
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2009
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2002
8	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 08/2013
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2019 - 09/2010
7	CytokinesIBA 08/2013 - 03/2003
6	Complement System Proteins (Complement)IBA 01/2023 - 01/2010
6	Infliximab (Remicade)FDA Link 01/2021 - 06/2007
6	SteroidsIBA 01/2018 - 05/2007
6	Interleukin-10 (Interleukin 10)IBA 01/2013 - 08/2005
5	Immunosuppressive Agents (Immunosuppressants)IBA 10/2017 - 05/2007
5	Proteins (Proteins, Gene)FDA Link 09/2017 - 06/2004
5	Prednisone (Sone)FDA LinkGeneric 09/2016 - 05/2007
5	Tacrolimus (Prograf)FDA LinkGeneric 06/2012 - 05/2005
4	AntibodiesIBA 01/2023 - 08/2013
4	EndotoxinsIBA 01/2019 - 11/2015
4	Fluorescein (Funduscein)FDA LinkGeneric 04/2018 - 01/2010
4	Monoclonal AntibodiesIBA 01/2017 - 05/2011
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2015 - 05/2005
3	Interleukin-33IBA 11/2020 - 02/2015
3	C-Reactive ProteinIBA 01/2020 - 03/2016
3	Interleukin-6 (Interleukin 6)IBA 09/2019 - 01/2017
3	AntigensIBA 01/2018 - 09/2008
3	Peptides (Polypeptides)IBA 05/2015 - 11/2002
2	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 01/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 06/2004
2	EpitopesIBA 11/2021 - 10/2015
2	Immunologic Factors (Immunomodulators)IBA 10/2021 - 09/2016
2	Immunomodulating AgentsIBA 01/2021 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 03/2020
2	Particulate MatterIBA 11/2020 - 11/2019
2	tocilizumab (atlizumab)FDA Link 03/2020 - 01/2018
2	LipopolysaccharidesIBA 01/2019 - 07/2010
2	Bevacizumab (Avastin)FDA Link 04/2018 - 08/2013
2	Oxygen (Dioxygen)IBA 01/2017 - 09/2008
2	GlucocorticoidsIBA 09/2016 - 12/2007
2	Antinuclear AntibodiesIBA 03/2016 - 01/2014
2	Sirtuin 1IBA 05/2015 - 05/2013
2	Interleukin-17 (Interleukin 17)IBA 07/2014 - 04/2013
2	LigandsIBA 06/2014 - 01/2012
2	InterferonsIBA 04/2014 - 05/2007
2	Protein Isoforms (Isoforms)IBA 09/2013 - 08/2013
2	Fingolimod Hydrochloride (FTY720)FDA Link 02/2012 - 10/2008
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2010 - 07/2010
2	Phosphorus (Red Phosphorus)IBA 01/2010 - 06/2008
1	Indicators and Reagents (Reagents)IBA 08/2023
1	TriazolesIBA 11/2022
1	Coloring Agents (Dyes)IBA 11/2022
1	Penicillin G Procaine (Procaine, Benzylpenicillin)FDA Link 10/2022
1	Probenecid (Benemid)FDA LinkGeneric 10/2022
1	ElastinIBA 11/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Nitrogen OxidesIBA 11/2020

Therapy/Procedure

31	Therapeutics 12/2022 - 01/2004
5	Lasers (Laser) 02/2016 - 04/2010
4	Biological Therapy 10/2018 - 05/2007
3	Intravitreal Injections 10/2021 - 11/2016
3	Immunomodulation 01/2018 - 03/2016
2	Time-to-Treatment 01/2019 - 01/2017
2	Radiotherapy 01/2018 - 01/2008
2	Immunotherapy 09/2008 - 06/2004
1	Precision Medicine 01/2023